SAN MATEO, Calif., June 4, 2009 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) today announced that management will present at the Goldman Sachs Healthcare Conference on Tuesday, June 9th at 3:45 p.m. Eastern Time. Pain Therapeutics' management will also present at the Needham Life Sciences Conference on Thursday, June 11th at 1:30 p.m. Eastern Time.
Both presentations will be webcast live and may be accessed from "News" on the home page of Pain Therapeutics' website at www.paintrials.com. A replay of the webcasts will also be available on the website for two weeks following the presentations.
About Pain Therapeutics, Inc.
Pain Therapeutics, Inc. is a biopharmaceutical company that develops novel drugs. In addition to REMOXY(r), a unique abuse-resistant controlled-release oxycodone, the Company has three drug candidates in clinical programs, including a novel radio-labeled monoclonal antibody to treat metastatic melanoma, as well as PTI-202 and PTI-721. Pain Therapeutics is also working on a new treatment for patients with hemophilia.